28468980|t|Identification of protective B-cell epitopes within the novel malaria vaccine candidate P. falciparum Schizont Egress Antigen-1
28468980|a|Naturally -acquired antibodies to PfSEA-1A are associated with protection against severe malaria in children. Vaccination of mice with PbSEA-1A decreases parasitemia and prolongs survival following Plasmodium berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear, B-cell epitopes using peptide microarrays probed with anti-sera from rPfSEA-1A - vaccinated non-human primates. We evaluated the relationship between epitope -specific antibody levels and protection from parasitemia in a longitudinal treatment - reinfection cohort in Western Kenya. Antibodies to three epitopes were associated with 16-17% decreased parasitemia over an 18- week high transmission season. We are currently designing immunogens to enhance antibody responses to these three epitopes.
28468980	29	44	B-cell epitopes	T103	UMLS:C0282581
28468980	62	77	malaria vaccine	T103	UMLS:C0206255
28468980	88	127	P. falciparum Schizont Egress Antigen-1	T103	UMLS:C3849939
28468980	148	158	antibodies	T103	UMLS:C0003241
28468980	162	170	PfSEA-1A	T103	UMLS:C3849939
28468980	217	224	malaria	T038	UMLS:C0024530
28468980	238	249	Vaccination	T058	UMLS:C0042196
28468980	253	257	mice	T204	UMLS:C0025929
28468980	263	271	PbSEA-1A	T103	UMLS:C4040232
28468980	282	293	parasitemia	T038	UMLS:C0242723
28468980	326	349	Plasmodium berghei ANKA	T204	UMLS:C0032149
28468980	376	390	immunogenicity	T038	UMLS:C4277607
28468980	394	402	PfSEA-1A	T103	UMLS:C3849939
28468980	431	446	B-cell epitopes	T103	UMLS:C0282581
28468980	453	460	peptide	T103	UMLS:C0030956
28468980	485	494	anti-sera	T103	UMLS:C0020960
28468980	500	509	rPfSEA-1A	T103	UMLS:C3849939
28468980	512	522	vaccinated	T033	UMLS:C1519885
28468980	533	541	primates	T204	UMLS:C0033147
28468980	546	555	evaluated	T058	UMLS:C0220825
28468980	581	588	epitope	T103	UMLS:C0003316
28468980	599	607	antibody	T103	UMLS:C0003241
28468980	635	646	parasitemia	T038	UMLS:C0242723
28468980	665	674	treatment	T058	UMLS:C0087111
28468980	689	695	cohort	T098	UMLS:C0599755
28468980	699	712	Western Kenya	T082	UMLS:C0022558
28468980	714	724	Antibodies	T103	UMLS:C0003241
28468980	734	742	epitopes	T103	UMLS:C0003316
28468980	781	792	parasitemia	T038	UMLS:C0242723
28468980	863	873	immunogens	T103	UMLS:C0042213
28468980	885	903	antibody responses	T038	UMLS:C0003261
28468980	919	927	epitopes	T103	UMLS:C0003316